Screening for heparin binding variants of antithrombin.
Open Access
- 1 June 1991
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 44 (6) , 477-479
- https://doi.org/10.1136/jcp.44.6.477
Abstract
A chromogenic assay for use as a screening test for the identification of antithrombin deficiency is described. The heparin concentration and the incubation time in the assay were optimised specifically to permit the detection of heparin binding defects of antithrombin. The sensitivity of antithrombin assays for the detection of this type of variant was significantly impaired when an incubation time of more than 30 seconds was used. Several commercially available assays recommend a longer incubation time than 30 seconds and therefore some patients with heparin binding defects of antithrombin may not be identified. The assay described here allows heparin binding variants of antithrombin to be identified and distinguished from other types of antithrombin deficiency in a simple two stage procedure.Keywords
This publication has 6 references indexed in Scilit:
- Molecular genetics of inherited antithrombin III deficienciesThe American Journal of Medicine, 1989
- HEPARIN BINDING DEFECT IN A NEW ANTI-THROMBIN-III VARIANT - ROUEN, 47 ARG TO HIS1987
- Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisBlood, 1987
- Antithrombin III Deficiency and ThromboembolismClinics in Haematology, 1981
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Actions and Interactions of Antithrombin and HeparinNew England Journal of Medicine, 1975